Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

被引：0
|
作者：
Barbara Rossi
Giovanni Schinzari
Giulio Maccauro
Laura Scaramuzzo
Diego Signorelli
Michele A Rosa
Carlo Fabbriciani
Barone Carlo
机构：
[1] Catholic University,Department of Orthopaedics and Traumatology
[2] Agostino Gemelli Hospital,Department of Medical Oncology
[3] Catholic University,Department of Orthopaedics
[4] Agostino Gemelli Hospital,undefined
[5] Messina University,undefined
来源：
BMC Musculoskeletal Disorders | / 11卷
关键词：
Vascular Endothelial Growth Factor; Osteosarcoma; Vascular Endothelial Growth Factor Expression; Local Relapse; High Grade Osteosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma
    Leavey, PJ
    Mantadakis, E
    Maale, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2002, 19 (07) : 483 - 489
  • [22] EXPERIENCE WITH PREOPERATIVE, HIGH-DOSE METHOTREXATE (HDMTX) CONTAINING CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA (OSA)
    HONEGGER, HP
    CSERHATI, MD
    VONHOCHSTETTER, A
    HOFMANN, V
    GROSCURTH, P
    CANCER DRUG DELIVERY, 1986, 3 (01): : 69 - 69
  • [23] Neoadjuvant chemotherapy with high-dose ifosfamide, doxorubicin and cisplatin in nonmetastatic osteosarcoma of the extremity.
    Kudawara, I
    Leguchi, M
    Aoki, Y
    Naka, N
    Araki, N
    Nakanishi, H
    Matsumine, A
    Myoui, A
    Ueda, T
    Yoshikawa, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 827S - 827S
  • [24] DOSAGE ADJUSTMENT OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA
    PIGNON, T
    LACARELLE, B
    GUILLET, P
    DUFFAUD, F
    CATALIN, J
    DURAND, A
    FAVRE, R
    BULLETIN DU CANCER, 1994, 81 (11) : 976 - 978
  • [25] Toxicity of high-dose chemotherapy in patients with osteosarcoma
    Guskova, Nailya
    Kit, Oleg Ivanovich
    Kuznetsov, Sergei A.
    Maslov, Andrey A.
    Starzhetskaya, Maria V.
    Bespalova, Aleksandra I.
    Guskova, Ekaterina
    Belgova, Svetlana V.
    Nozdricheva, Anastasia
    Myagkova, Tatiana Yu.
    Donskaya, Aliya K.
    Gusareva, Marina A.
    Avanesova, Kristina
    Abakumova, Svetlana V.
    Tselishcheva, Irina V.
    Golomeeva, Nadezhda
    Torpudzhyan, Izabella
    Lisunova, Zinaida P.
    Zakharchenko, Viktoria
    Zekhtser, Ineya I.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] High-dose methotrexate population pharmacokinetic and pharmacogenetic analysis in pediatric patients with osteosarcoma
    Lui, G.
    Treluyer, J. M.
    Fresneau, B.
    Le Deley, M. C.
    Le Teuff, G.
    Brugieres, L.
    Bouazza, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 42 - 43
  • [27] The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone
    Ham, SJ
    Hoekstra, HJ
    vanderGraaf, WTA
    Kamps, WA
    Molenaar, WM
    Koops, HS
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 490 - 496
  • [28] High-dose Methotrexate Is Effective in Osteosarcoma so What Is the Problem?
    Cohen, Ian Joseph
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (12) : 892 - 894
  • [29] Outpatient administration of high-dose methotrexate for osteosarcoma treatment in Brazil
    Macedo, C. R.
    Cappellano, A. M.
    Noguchi, D. T.
    Martinho, A. P.
    Dias, C. G.
    Dias, C. G.
    Malheiros, R. C.
    Dutra, A. H.
    Grings, M.
    Pires, A. L.
    Petrilli, A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] THE UNCLEAR ROLE OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA (OS)
    RICHARDS, JM
    VOGELZANG, NJ
    SIMON, M
    CLINICAL RESEARCH, 1986, 34 (04): : A932 - A932
12345